β-Amyloid peptides 1–40βA and 25–35βA suppress human amylin-mediated death of RINm5F islet β-cells with distinct actions on fibril formation

Authors

  • Ji-Zhong Bai

    Corresponding author
    1. Department of Physiology, School of Medical and Health Sciences, University of Auckland, Private Bag 9201, Auckland, New Zealand
    Search for more papers by this author

Tel.: +64 9 373 7599x86205; fax: +64 9 373 7499. j.bai@auckland.ac.nz

Abstract

Amyloid deposition is a common feature of Alzheimer's disease and type 2 diabetes related to β-amyloid peptides (βA) and human amylin (hA), respectively. Both βA and hA form aggregates and fibrils and kill cultured cells. To investigate whether βA and hA display peptide-specific toxicity on cultured islet β-cells, we examined the effects of 1–40βA and 25–35βA peptides on hA-mediated cell death and [125I-Tyr37]hA precipitation. Synthetic hA aggregated in solution and evoked both conformation- and sequence-dependent cell death. While neither 1–40βA nor 25–35βA was toxic to islet β-cells, they suppressed hA-evoked cell death in a concentration-dependent and saturable manner. Only 1–40βA, but not 25–35βA, showed trophic effects on cultured islet β-cells and inhibited the precipitation of [125I]hA caused by hA. These results suggest that 25–35βA does not interfere with hA-mediated fibril formation. Suppression of hA-evoked death of cultured pancreatic islet β-cells by the βA peptides is likely to occur through a competing interaction at these cells.

Ancillary